Ligne de temps

Thomas Moreau
Post-doctorant(e)
17 oct. 2025
publication

IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodies.

Lire plus
14 sept. 2025
publication

Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositis.

Lire plus
01 août 2023
publication

Heterogeneity and functions of the 13 IFN-α subtypes – lucky for some?

Lire plus
02 juil. 2020
team

Immunologie Translationnelle

Lire plus